Cargando…
Converging global crises are forcing the rapid adoption of disruptive changes in drug discovery
Spiralling research costs combined with urgent pressures from the Coronavirus 2019 (COVID-19) pandemic and the consequences of climate disruption are forcing changes in drug discovery. Increasing the predictive power of in vitro human assays and using them earlier in discovery would refocus resource...
Autores principales: | Treherne, J. Mark, Langley, Gillian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129828/ https://www.ncbi.nlm.nih.gov/pubmed/34015541 http://dx.doi.org/10.1016/j.drudis.2021.05.001 |
Ejemplares similares
-
Expanding roles for academic entrepreneurship in drug discovery
por: Kinch, Michael S., et al.
Publicado: (2020) -
Care in crises: Nursing and humanitarian aid
por: Freeman, Anna
Publicado: (2018) -
The Influence of the COVID-19 Pandemic on Technology: Adoption in Health Care
por: Clipper, Bonnie
Publicado: (2020) -
COVID and the convergence of three crises in Europe
por: Bozorgmehr, Kayvan, et al.
Publicado: (2020) -
Variation of hospital-based adoption of care coordination services by community-level social determinants of health
por: Chen, Jie, et al.
Publicado: (2020)